STAMP- Xenium for cytokine release syndrome analysis in PBMCs

Xenium stamp for CRS analysis

Table of Contents

Presented at the 10x Genomics x Novartis Single-Cell & Spatial Day on June 18th 2026, this cytokine release syndrome study in human PBMCs combines Cytometric Bead Array (CBA)-based cytokine profiling and Xenium analysis with the IO panel.

The take-home message: CBA + Xenium STAMP lets you know what is secreted, by which cells, and through which transcriptomic program. In short, Xenium STAMP is a cost-effective approach that brings single-cell mechanistic insights to cell-based assays driven by functional readouts.

Download the case study: “STAMP- Xenium - Cytokine Release Syndrome case study”

Could your program use this approach?
Talk to us
Explicyte Oncology CRO logo

Capabilities

Modalities